Publications

Lasmiditan (COL-144) a Selective 5-HT1F agonist, is a rapid & effective oral treatment for acute migraine

Sep 1 2011

File available:

2010_ehmtic_ph2_oral_poster_sept2010.pdf

Source: European Headache & Migraine Trust Ingernational Congress 2010

Back to List

Clinical Trial Information

For further information about our ongoing clinical trials, please visit clinicaltrials.gov. ClinicalTrials.gov is a database providing information about all federally or privately funded clinical trials taking place worldwide.